Sanofi : Clear direction underpins our sentiment
>A convincing capital market day - Sanofi yesterday held a capital market day which largely lived up to our expectations. Management's ambition to step up growth is based on three key focus areas: 1/ developing Dupixent and vaccines, 2/ focusing on six core compounds in the pipeline, and 3/ improving profitability (€ 2bn of cost cutting out to 2022).We think it is reasonable to expect a large chunk of the consensus to adjust quickly to the core EBIT guidance at ...Sanofi is an integrated, global healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. Two segments make up Co.'s business: Pharmaceuticals and Vaccines. The Pharmaceuticals segment covers research, development, production and marketing of medicines, consisting of flagship products, plus a broad range of prescription medicines, generic medicines, and consumer health products. The Vaccines segment includes research, development, production and marketing of vaccines in five areas: pediatric vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.